NSC |
Compound |
Enrichment |
Correlation |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0392716453377535 |
-0.20847987 |
NSC 715407 |
Null |
0.0392716453377535 |
0.07862177 |
NSC 716503 |
Null |
0.0392716453377535 |
-0.012626815 |
NSC 717468 |
Null |
0.0392716453377535 |
0.22758697 |
NSC 718564 |
Null |
0.0392716453377535 |
0.25100522 |
NSC 718781 |
Erlotinib hydrochloride |
0.0392716453377535 |
-0.24912019 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.0392716453377535 |
0.14599422 |
NSC 725098 |
Null |
0.0392716453377535 |
0.36976937 |
NSC 726089 |
11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate |
0.0392716453377535 |
0.49084984 |
NSC 729166 |
N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide |
0.0392716453377535 |
0.079322363 |